Comparison of wound treatment and wound healing with a hyaluronic acid-containing matrix vs. hydrofibre and skin transplant healing rates for defect coverage after resection of skin tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006293

Enrollment

Registered

2014-07-03

Start date

2014-07-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C43 C44

Interventions

Group 1: After tumor excision wound treatment with Hyalomatrix (Anika Therapeutics S.r.l) followed by autologous skin graft Group 2: After tumor excision open wound treatment with Aqaucel (Convatec) f

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Skin Tumor in need of excision and skin transplantation

Exclusion criteria

Exclusion criteria: Persons aged under 18, Wound infection before surgery, missing informed consent

Design outcomes

Primary

Measure	Time frame
Skin transplant take rate 1 week after grafting, as well as after 6-12 months. Scar evaluation with POSAS scar scale and high resolution skin ultrasound examination	—

Secondary

Measure	Time frame
Pain during wound dressing after tumor excision with visual analog pain scale (VAS) scar quaulity (POSAS scar scale) 6-12 months after skin grafting	—

Countries

Germany

Contacts

Public ContactAlbrecht Krause-Bergmann

Fachklinik HornheideAbteilung für Plastische und Ästhetische Chirurgie, Handchirurgie

pl-chir@fachklinik-hornheide.de0251-3287-441

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026